Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia

Hematology and Cell Therapy

Volumn 41, Issue 3, 1999, Pages 117-125

  Mandelli, Franco ^a   Lauria, Francesco ^a   Majolino, Ignazio ^a   Meloni, Giovanna ^a   Santini, Gino ^a   Foà, Robin ^a   Castoldi, Gianluigi ^a   Corradini, Paolo ^a   Falini, Brunangelo ^a   Pileri, Stefano ^a   Liso, Vincenzo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; MITOXANTRONE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0345104429     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lee JS, Dixson DO, Kantarjian HM, Keating MJ, Talpaz M (1987) Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood 69: 1929-36
2. Rai KR, Sawitsky A, Cronkite EP, Levy RN, Pasternach DS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219-34
3. Binet JL, Auguier A, Dighiero G, et al. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198-206
4. International Workshop on chronic lymphocytic leukemia (1989) Chronic lymphocytic leukemia: reccomandations for diagnosis, staging and response criteria. Ann Int Med 110: 236-238
5. Montserrat E, Sanchez-Bisono J, Vinolas N, Rozman C (1986) Lymphocytic doubling time in CLL: analysis of prognostic significance. Br J Haematol 62: 567-75
6. Molica S, Alberti A (1987) Prognostic value of the lymphocyte duobling time in chronic lymphocytic leukemia. Cancer 60: 2712-16
7. Rozman C, Montserrat E, Rodriguez, Fernandez JM, et al. (1984) Bone marrow histologic pattern, the best single prognostic parameter in chronic lymphocytic leukemia; a multivariate survival analysis of 329 cases. Blood 64: 642-8
8. The French Cooperative Group on CLL. Johnson S, Smith AG, Loffler H, et al. (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukemia. Lancet 347: 1432-1438.
9. Keating MJ, O' Brien S, Lerner S, et al. (1998) Long-term follow-up of patients with chronic lymphocytic leukemia receiving fludarabine regimens as initial therapy. Blood 92: 1165-1171
10. Provan D, Bartlett-Pandite L, Zwicky C, et al. (1996) Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation, Blood 88: 2228-35
11. Michallet M, Van Biezan A, Bandini G, et al. (1998) Hematopoietic stem cell transplantation for chronic lymphocytic leukemia (CLL). 24nd Annual Meeting of the EBMT Courmayeur, March 22-26. Bone Marrow Transplant 21(1) Abs 273
12. Meloni G, Mauro FM, Proia A, Mandelli F (1998) Chronic kymphocytic leukemia: from palliative therapy to curative intent. Haematologica 83: 660-662
13. Rabinowe SN, Soiffer RJ, Gribben JG, Nadler LM (1993) Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lympocytic leukemia. Blood 82: 1366-1376
14. Khouri IF, Keating MJ, Vriesendorp HM, Reading CL, Champlin RE (1994) Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J Clin Oncol 12: 748-58
15. Scimè R, Indovina A, Santoro A, et al. PBSC mobilization, collection and positive selection in patients with chronic lymphocitic leukemia. Bone Marrow Transplant (in press)
16. Scimè R, Santoro A, Musso M, et al. (1997) Peripheral CD34+ cell autograft in CLL: preliminary results of a cooperative study. Blood 90 (suppl. 11): 407b
17. Meloni G, Mauro f, Guglielmi C, et al. (1996) Peripheral blood stem cell transplantation in CLL patients in remission after fludarabine therapy. A feasibility study. Bone Marrow Transplant 17 (1): S 105
18. Dreger P, Viehmann K, von Neuhoff N, et al. (1996) Treatment of chronic lymphatic leukemia in patients of young age: the curative potential of autologous stem cell transplantation. Bone Marrow Transplant 17(1): S 146
19. To LB, Roberts MM, Hylock DN, et al. (1992) Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9: 277-284
20. Champlin R (1996) Purging: the separation of normal from malignant cells for autologous transplantation. Transfusion 36: 910-18
21. Paulus U, Schmitz N, Viehmann K, von Neuhoff N and Dreger P (1997) Combined positive/negative selection for highly effective purging of PBSC grafts: towasd clinical application in patients with B-CLL. Bone Marrow Transplant 20: 415-20
22. Itala M, Pelliniemi T, Rajamaki R and Remes K (1997) Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield. Bone Marrow Transplant 19: 647-651
23. Billeadeu D, Blackstadt M, Greipp B, et al. (1991) Analysis of B lymphoid malignancies using allele specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood 78: 3021-29
24. Corradini P, Astolfi M, Cherasco C, et al. (1997) Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 89: 724-31
25. Robertson LE, O' Brien S, Kantarijan H, Koller C and Keating MJ (1995) A three-day schedule of fludarabine in previously treated chronic lymphocytic leukemia. Leukemia 9: 1444-49
26. 2 plus rh G-CSF for mobilization of circulating proge-nitor cells in malignant lymphomas. Int J Art Organs 16: (suppl. 5) 30-34
27. Gianni AM, Bregni M, Siena S, et al. (1990) Recombinant human GM-CSF reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 8: 768
28. Cheson B, Bennett JM, Grever M, et al. (1996) National Cancer Institute Sponsored Working Group Guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4990-97
29. Keating MJ, O' Brien S, Kantarijan H, et al. (1993) Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood 81: 2878-2884
30. Robertson LE, Huh YO, Butler JJ, et al. (1992) Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic and molecular analysis. Blood 80: 29-36
31. Bence-Bruckler I, Bredeson C, Atkins H, et al. (1998) A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation. Bon Marrow Transpl 22: 965-969